ATS 2019 Virtual Final Program

111 We Ran Out of Talc! Outcomes of Outpatient Povidone Iodine Pleurodesis Via Indwelling Pleural Catheter in Refractory and Recurrent Non-Malignant Non-Infected Pleural Effusions/ J. Crossan, S. Kalluri, F. Kheir, U.R. Kaphle, Y. Sangwan, Salisbury, MD, p.A1100 112 Intra-Pleural Lytics - How Low Can We Go? An Institutional Experience with a Unique Low Dose Adaptive Protocol/ J. Crossan, S. Kalluri, U.R. Kaphle, F. Kheir, S. Sheth, Y. Sangwan, Salisbury, MD, p.A1101 113 Post Cardiac Surgery Pleural Effusions and Thoracentesis/ M. Dorry, S.L. Shofer, Z. Healy, F. Jaamour, M.M. Wahidi, Durham, NC, p.A1102 114 AFB Culture in EBUS Guided TBNA and Role of Gene Xpert/RIF Assay in Diagnosis of Mycobacterium Tuberculosis/ A.C. Shah, U.C. Shah, C.M. Shah, Vadodara, India, p.A1103 115 Endobronchial Embolization with Silicone Spigots in the Management of Hemoptysis/ A. Yamada, H. Saka, M. Oki, C. Kitagawa, Y. Kogure, S. Oka, M. Nakahata, Y. Ise, H. Niwa, A. Ishida, F. Shigematsu, A. Torii, Nagoya-shi, Japan, p.A1104 116 Patient Satisfaction 1 Year After Bronchoscopic Lung Volume Reduction Treatment Using Endobronchial Valves in Severe Emphysema Patients/ J. Hartman, K. Klooster, N. ten Hacken, D.-J. Slebos, Groningen, Netherlands, p.A1105 117 Endobronchial Valve Placement for Persistent Air Leaks in the Setting of Infectious Cavitary Lesions and Necrotizing Pneumonia/ A.S. Flora, S. Benzaquen, Cincinnati, OH, p.A1106 118 In-Hospital Mortality and Early Arterial Embolization in Patient with Hemoptysis Requiring Mechanical Ventilation/ T. Ando, T. Jo, M. Kawashima, H. Kage, G. Tanaka, Y. Yamauchi, M. Suzukawa, K. Masuda, H. Yasunaga, T. Nagase, Tokyo, Japan, p.A1107 119 A Decade of Endobronchial Ultrasound (EBUS) Guided Transbronchial Needle Aspiration (TBNA) in a Single Tertiary Referral Center in Ireland/ R.P. Cusack, A. O’Reilly, S. Roche, G.A. Kavanagh, R.J. Fahy, P. Nadarajan, F. O’Connell, Dublin, Ireland, p.A1108 120 Diagnostic Value and Safety of Endobronchial Ultrasound (EBUS) Guided Trans Bronchial Needle Aspiration (TBNA) of Mediastinal or Peribronchial Masses in a Tertiary Referral Centre in Ireland/ R.P. Cusack, S. Roche, A. O’Reilly, G.A. Kavanagh, R.J. Fahy, P. Nadarajan, F. O’Connell, Dublin, Ireland, p.A1109 121 The Effect of Interventional Pulmonology on the Training of Pulmonary and Critical Care Fellows/ S. Alamro, M. Sierra-Ruiz, J.P. Becerra, A. Agnew, A. Majid, M.S. Parikh, A. Chee, Boston, MA, p.A1110 122 Incidence and Nature of Respiratory Impairment in Consecutive Patients Undergoing Bronchoscopy Under Conscious Sedation/ A. Tariq, N.S. Hill, K. Ismail, Boston, MA, p.A1111 CLINICAL POSTER DISCUSSION SESSION A24 COPD: THERAPY, IMAGING, AND MOLECULAR MARKERS 9:15 a.m. - 11:15 a.m. KBHCCD Room C141/C143/C149 (Level 1) Poster Viewing 9:15-10:00 Discussion 10:00-11:15 Chairing: J. Allinson, MRCP(UK), London, United Kingdom B.J. Make, MD, Denver, CO 201 Eosinophil Counts as a Biomarker of Oral Corticosteroid Treatment Success for Patients with COPD/ M. Kerkhof, I. Chaudhry, J. Kocks, I. Pavord, D. Halpin, O. Usmani, T. Morris, M. Alacqua, D. Price, Singapore, Singapore, p.A1112 202 Differences in GOLD 2017 Treatment Group Assignments Between the COPD Assessment Test and Modified Medical Research Council Dyspnea Scale and Their Association with Exacerbations: An Analysis of the SPIROMICS Cohort/ S.R. Ocheltree, E. Male, H. Zhao, C.H. Martinez, C.B. Cooper, E.R. Bleecker, R.C. Boucher, J.L. Curtis, N.N. Hansel, I. Barjaktarevic, R.G. Barr, R.E. Kanner, R.A. Wise, M. Kesimer, R. Paine 3rd, N. Putcha, S.I. Rennard, D.P. Tashkin, P. Woodruff, M.K. Han, F.J. Martinez; G.J. Criner, V. Kim, Philadelphia, PA, p.A1113, p.A1113 203 The Use of Oscillating Positive Expiratory Pressure (OPEP) Therapy in Patients with COPD or Chronic Bronchitis with Excess Mucus Secretion: A Randomized Controlled Trial/ M. van Es, S. Schokker, S. Been-Buck, W. Wiersema, T. Klemmeier-Boekholt, W. Jacobs, Groningen, Netherlands, p.A1114 204 Effect of a 3-Month Low-Dose Azithromycin Intervention for COPD Exacerbations Requiring Hospitalization on Subsequent Respiratory Events and Mortality - The BACE Trial/ W. Janssens, K. Vermeersch, T. Troosters, G.G. Brusselle, Leuven, Belgium, p.A1115 205 InforMing the PAthway of COPD Treatment (The IMPACT Study): Single Inhaler Triple Therapy (Fluticasone Furoate/Umeclidinium/Vilanterol) Versus Fluticasone Furoate/Vilanterol and Umeclidinium/Vilanterol in Patients With COPD: An Analysis Based on Baseline / D. Singh, G.J. Criner, M.T. Dransfield, D.M.G. Halpin, M.K. Han, C.E. Jones, S. Kilbride, P. Lange, D.A. Lomas, F.J. Martinez, S.J. Pascoe, R.A. Wise, D.A. Lipson, Manchester, United Kingdom, p.A1116 206 Patients in Clinical Trials on COPD Triple Therapy Compared to Real World Populations/ R. Buhl, C.-P. Criée, P. Kardos, K. Berschneider, V. Obermoser, C. Vogelmeier, H. Worth, Mainz, Germany, p.A1117 207 Improving the Accuracy of Airway Wall Measurements Using Deep Learning/ P. Nardelli, A.A. Diaz, G.R. Washko, R. San Jose Estepar, Boston, MA, p.A1118 ATS 2019 • Dallas, TX SUNDAY • MAY 19 37 SUNDAY MORNING